Stem (NYSE:STEM) Price Target Lowered to $2.50 at UBS Group

Stem (NYSE:STEM) had its price objective lowered by UBS Group from $5.00 to $2.50 in a research report released on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock.

Other research analysts have also recently issued research reports about the stock. BMO Capital Markets decreased their price objective on shares of Stem from $2.50 to $1.85 and set a market perform rating for the company in a report on Friday, May 3rd. Evercore ISI lowered their price objective on shares of Stem from $13.00 to $9.00 and set an outperform rating for the company in a research report on Friday, May 3rd. Piper Sandler dropped their price objective on Stem from $3.00 to $2.00 and set a neutral rating on the stock in a research note on Thursday, April 11th. Susquehanna decreased their target price on Stem from $5.50 to $4.00 and set a positive rating for the company in a research note on Thursday, February 29th. Finally, The Goldman Sachs Group dropped their price target on Stem from $2.50 to $2.00 and set a neutral rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of Hold and a consensus target price of $4.77.

Stem Stock Performance

Shares of Stem stock opened at $1.37 on Wednesday. The firm has a fifty day moving average of $1.90 and a two-hundred day moving average of $2.78. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.78 and a current ratio of 1.88. The stock has a market capitalization of $215.36 million, a price-to-earnings ratio of -0.94 and a beta of 1.91. Stem has a 52 week low of $1.27 and a 52 week high of $7.79.

Stem (NYSE:STEM) last released its quarterly earnings data on Thursday, May 2nd. The company reported ($0.46) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.25). The company had revenue of $25.50 million during the quarter, compared to the consensus estimate of $66.67 million. Stem had a negative net margin of 40.03% and a negative return on equity of 34.37%. The company’s revenue for the quarter was down 61.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.29) EPS. As a group, equities research analysts predict that Stem will post -0.51 EPS for the current year.

Insider Buying and Selling

In other Stem news, Director David S. Buzby purchased 33,800 shares of the stock in a transaction on Monday, March 18th. The shares were purchased at an average cost of $1.81 per share, for a total transaction of $61,178.00. Following the purchase, the director now owns 768,448 shares of the company’s stock, valued at $1,390,890.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, Director David S. Buzby purchased 33,800 shares of the firm’s stock in a transaction on Monday, March 18th. The stock was purchased at an average cost of $1.81 per share, for a total transaction of $61,178.00. Following the completion of the purchase, the director now directly owns 768,448 shares in the company, valued at $1,390,890.88. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Robert Schaefer sold 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $1.82, for a total value of $182,000.00. Following the sale, the insider now owns 716,110 shares in the company, valued at approximately $1,303,320.20. The disclosure for this sale can be found here. Over the last 90 days, insiders acquired 130,418 shares of company stock worth $238,045 and sold 772,268 shares worth $1,650,229. 10.17% of the stock is currently owned by corporate insiders.

Institutional Trading of Stem

A number of large investors have recently added to or reduced their stakes in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in Stem by 106.5% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 6,341,334 shares of the company’s stock valued at $26,887,000 after purchasing an additional 3,271,193 shares during the last quarter. Electron Capital Partners LLC lifted its position in shares of Stem by 62.2% in the third quarter. Electron Capital Partners LLC now owns 4,978,739 shares of the company’s stock valued at $21,110,000 after buying an additional 1,909,478 shares during the last quarter. Lido Advisors LLC bought a new position in shares of Stem during the 3rd quarter worth approximately $4,561,000. Alkeon Capital Management LLC increased its holdings in shares of Stem by 34.6% during the 3rd quarter. Alkeon Capital Management LLC now owns 3,888,612 shares of the company’s stock worth $16,488,000 after acquiring an additional 1,000,000 shares during the last quarter. Finally, Rock Point Advisors LLC raised its stake in Stem by 104.7% in the 4th quarter. Rock Point Advisors LLC now owns 1,407,525 shares of the company’s stock valued at $5,461,000 after acquiring an additional 720,080 shares during the period. Institutional investors and hedge funds own 61.63% of the company’s stock.

About Stem

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.